Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics
Joanna M. Woodcock(South Australia Pathology), Angel F. López(Centre for Cancer Biology)
Cited by 38
Related Papers
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
|Leukemia|2016|50
GM‐CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid‐derived suppressor cells <i>in vitro</i>
|Clinical & Translational Immunology|2016|36
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
|Cancer Discovery|2023|11